CVT-4325 Inhibits Myocardial Fatty Acid Uptake and Improves Left Ventricular Systolic Function without Increasing Myocardial Oxygen Consumption in Dogs with Chronic Heart Failure

Author： Imai Makoto   Rastogi Sharad   Sharma Naveen   Chandler Margaret   Sharov Victor   Blackburn Brent   Belardinelli Luiz   Stanley William   Sabbah Hani  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.21, Iss.1, 2007-02, pp. : 9-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Nebivolol versus Carvedilol on Left Ventricular Function in Patients with Chronic Heart Failure and Reduced Left Ventricular Systolic Function

By Lombardo Renzo M.R.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 4, 2006-01 ,pp. : 259-263

Adis International

Access to resources Recommend Favorite

Eplerenone: A Review of its Use in Left Ventricular Systolic Dysfunction and Heart Failure After Acute Myocardial Infarction

By Gillian M. Keating   Greg L. Plosker  

Drugs, Vol. 64, Iss. 23, 2004-01 ,pp. : 2689-2707

Adis International

Access to resources Recommend Favorite

Valsartan: A Review of its Use in Patients with Heart Failure and/or Left Ventricular Systolic Dysfunction After Myocardial Infarction

By Katherine F. Croom   Gillian M. Keating  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 6, 2004-01 ,pp. : 395-404

Adis International

Access to resources Recommend Favorite

Nebivolol and carvedilol are comparable for patients with chronic heart failure and reduced left ventricular (LV) systolic function

By  

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Acute Intravenous Infusion of an Adenosine Regulating Agent Improves Left Ventricular Function in Dogs with Advanced Heart Failure

By Wang Mengjun   Gupta Ramesh   Rastogi Sharad   Kohli Smita   Zhang Kefei   Lanfear David   Sabbah Hani  

Cardiovascular Drugs and Therapy, Vol. 27, Iss. 6, 2013-12 ,pp. : 489-498

Springer Publishing Company

Access to resources Recommend Favorite